According to Cooper Companies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.87525. At the end of 2024 the company had a P/S ratio of 5.08.
Year | P/S ratio | Change |
---|---|---|
2024 | 5.08 | 20.18% |
2023 | 4.23 | 3.73% |
2022 | 4.08 | -42.03% |
2021 | 7.03 | 0.47% |
2020 | 7.00 | 30.01% |
2019 | 5.38 | 7.32% |
2018 | 5.02 | -8.46% |
2017 | 5.48 | 25.53% |
2016 | 4.37 | 5.94% |
2015 | 4.12 | -10.27% |
2014 | 4.59 | 17.61% |
2013 | 3.91 | 21.41% |
2012 | 3.22 | 29.13% |
2011 | 2.49 | 28.11% |
2010 | 1.94 | 66.03% |
2009 | 1.17 | 65.73% |
2008 | 0.7068 | -64.35% |
2007 | 1.98 | -33.68% |
2006 | 2.99 | -21.16% |
2005 | 3.79 | -19.34% |
2004 | 4.70 | 38.85% |
2003 | 3.39 | 30.49% |
2002 | 2.59 | -16.29% |
2001 | 3.10 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.85 | -21.08% | ๐บ๐ธ USA |
Novartis NVS | 3.96 | -18.73% | ๐จ๐ญ Switzerland |
Boston Scientific BSX | 7.56 | 55.11% | ๐บ๐ธ USA |
Teleflex TFX | 3.27 | -32.86% | ๐บ๐ธ USA |
Utah Medical Products UTMD | 4.80 | -1.56% | ๐บ๐ธ USA |
Atrion ATRI | 4.41 | -9.57% | ๐บ๐ธ USA |